Literature DB >> 21259183

Microwave ablation of liver metastases guided by contrast-enhanced ultrasound: experience with 125 metastases in 39 patients.

T Lorentzen1, B O Skjoldbye, C P Nolsoe.   

Abstract

PURPOSE: The aim of our study was to evaluate the efficacy of microwave (MW) ablation of liver metastases guided by B-mode ultrasound (US) and contrast-enhanced US (CEUS).
MATERIALS AND METHODS: 39 patients (17 women and 22 men) with a total of 125 liver metastases were treated with percutaneous or intraoperative CEUS-guided MW ablation. The primary tumor was colorectal cancer (n = 31), breast cancer (n = 6), carcinoid tumor (n = 1), and gastrointestinal stromal tumor (GIST) (n = 1). The median number of metastases ablated in the 45 treatment sessions was 2 (range 1 - 11). The median size (maximum diameter) of the 125 metastases was 1.5 cm (range, 0.6 - 4.0 cm). Nineteen (15 %) of the 125 metastases were bigger than 2 cm. Metastases smaller than 2 cm were treated with a single needle, metastases bigger than 2 cm were treated with 2 or 3 parallel needles.
RESULTS: The 45 MW ablation sessions were performed percutaneously (n = 30), during laparotomy (n = 3), or during laparotomy combined with liver resection (n = 12). The 39 patients were followed up for at least 4 months with a median duration of 11 months (range, 4 - 20 months). The technical success rate was 100 %. The clinical effectiveness was 100 % with complete coverage of the metastasis by the avascular coagulation zone evaluated on immediate post-ablation CEUS. Local tumor progression (local recurrence) was seen in 12 (9.6 %) of the 125 treated metastases, and affected 10 (26 %) of the 39 patients. One major complication was observed in the form of a liver abscess that easily resolved after percutaneous drainage. Four minor complications were observed: Three cases of pain located at the puncture site and one case of ascites. CEUS was valuable in all phases of ablation including pre-ablation staging and procedure planning, placement of MW needles in the tumor, immediate post-ablation control of coagulation size, and finally in the long term follow-up regime.
CONCLUSION: CEUS-guided MW ablation of liver metastases is an efficient and safe ablation technique with several advantages compared to other ablation modalities. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21259183     DOI: 10.1055/s-0029-1246002

Source DB:  PubMed          Journal:  Ultraschall Med        ISSN: 0172-4614            Impact factor:   6.548


  13 in total

Review 1.  Locoregional Therapies for the Treatment of Hepatic Metastases from Breast and Gynecologic Cancers.

Authors:  Samdeep K Mouli; Ramona Gupta; Neil Sheth; Andrew C Gordon; Robert J Lewandowski
Journal:  Semin Intervent Radiol       Date:  2018-04-05       Impact factor: 1.513

2.  CT imaging during microwave ablation: analysis of spatial and temporal tissue contraction.

Authors:  Dong Liu; Christopher L Brace
Journal:  Med Phys       Date:  2014-11       Impact factor: 4.071

Review 3.  Evolution of surgical microwave ablation for the treatment of colorectal cancer liver metastasis: review of the literature and a single centre experience.

Authors:  Stefan Stättner; Florian Primavesi; Vincent S Yip; Robert P Jones; Dietmar Öfner; Hassan Z Malik; Stephen W Fenwick; Graeme J Poston
Journal:  Surg Today       Date:  2014-03-16       Impact factor: 2.549

Review 4.  Microwave ablation in primary and secondary liver tumours: technical and clinical approaches.

Authors:  Maria Franca Meloni; Jason Chiang; Paul F Laeseke; Christoph F Dietrich; Angela Sannino; Marco Solbiati; Elisabetta Nocerino; Christopher L Brace; Fred T Lee
Journal:  Int J Hyperthermia       Date:  2016-08-02       Impact factor: 3.914

5.  Local tumour progression after ultrasound-guided microwave ablation of liver malignancies: risk factors analysis of 2529 tumours.

Authors:  Jie Yu; Ping Liang; Xiao-Ling Yu; Zhi-Gang Cheng; Zhi-Yu Han; Meng-Juan Mu; Qin-Ying Li; Yan-Mei Liu
Journal:  Eur Radiol       Date:  2014-11-19       Impact factor: 5.315

6.  Nanotechnology for cancer treatment.

Authors:  William H Gmeiner; Supratim Ghosh
Journal:  Nanotechnol Rev       Date:  2015-04       Impact factor: 7.848

Review 7.  Thermal ablation therapies in patients with breast cancer liver metastases: a review.

Authors:  Thomas J Vogl; Parviz Farshid; Nagy N N Naguib; Stephan Zangos
Journal:  Eur Radiol       Date:  2012-10-13       Impact factor: 5.315

Review 8.  Designing liver resections and pushing the envelope with resections for hepatic colorectal metastases.

Authors:  Mary L Guye; Hans F Schoellhammer; Louisa W Chiu; Joseph Kim; Lily L Lai; Gagandeep Singh
Journal:  Indian J Surg Oncol       Date:  2013-07-12

9.  Microwave ablation of liver metastases to overcome the limitations of radiofrequency ablation.

Authors:  Anna Maria Ierardi; Chiara Floridi; Federico Fontana; Claudio Chini; Francesca Giorlando; Filippo Piacentino; Luca Brunese; Graziella Pinotti; Alessandro Bacuzzi; Gianpaolo Carrafiello
Journal:  Radiol Med       Date:  2013-07-20       Impact factor: 3.469

Review 10.  Thermal ablation of liver metastases from colorectal cancer: radiofrequency, microwave and laser ablation therapies.

Authors:  Thomas J Vogl; Parviz Farshid; Nagy N N Naguib; Abbas Darvishi; Babak Bazrafshan; Emmanuel Mbalisike; Thorsten Burkhard; Stephan Zangos
Journal:  Radiol Med       Date:  2014-06-04       Impact factor: 3.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.